Hap Trading, LLC Fibrogen Inc Call Options Transaction History

Hap Trading, LLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2021 May 14, 2021	SELL	$31.0 - $55.72 $651,000 - $1.17 Million	-21,000 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$37.09 - $48.97 $778,890 - $1.03 Million	21,000 New	21,000 $7,000
Q1 2020 May 08, 2020	SELL	$23.3 - $45.96 $1.88 Million - $3.71 Million	-80,800 Closed	0 $0
Q4 2019 Feb 11, 2020	BUY	$34.58 - $48.06 $2.41 Million - $3.35 Million	69,700 Added 627.93%	80,800 $188,000
Q3 2019 Nov 12, 2019	SELL	$36.98 - $48.45 $399,383 - $523,260	-10,800 Reduced 49.32%	11,100 $13,000
Q2 2019 Aug 14, 2019	BUY	$35.13 - $55.53 $309,144 - $488,664	8,800 Added 67.18%	21,900 $123,000
Q4 2017 Feb 09, 2018	SELL	$41.95 - $60.1 $58,730 - $84,140	-1,400 Reduced 9.66%	13,100 $89,000
Q3 2017 Nov 08, 2017	BUY	$33.4 - $53.9 $484,300 - $781,550	14,500	14,500 $209,000

47.1M

387K

672K

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $32.8M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.